FEATURED COMPANIES
- 3Brain AG
- Axion BioSystems Inc.
- Harvard Bioscience Inc.
- MaxWell Biosystems AG
- Neuralynx Inc.
- Neuronexus
- MORE
Global In-Vitro And In-Vivo Micro Electrode Array Market 2020-2024
The in-vitro and in-vivo micro electrode array market is poised to grow by $ 5.49 mn during 2020-2024, progressing at a CAGR of 4% during the forecast period. The report on the in-vitro and in-vivo micro electrode array market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the extensive use of MEAs in neuroscience research, wide applications of in vitro CMOS-based MEAs, and the advent of 3D nanoparticle printing technology. In addition, Extensive use of MEAs in neuroscience research is anticipated to boost the growth of the market as well.
The in-vitro and in-vivo micro electrode array market analysis includes end-user segment, type segment, and geographical landscapes.
The in-vitro and in-vivo micro electrode array market is segmented as below:
By End-user
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The report on the in-vitro and in-vivo micro electrode array market covers the following areas:
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.
This market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
The in-vitro and in-vivo micro electrode array market is poised to grow by $ 5.49 mn during 2020-2024, progressing at a CAGR of 4% during the forecast period. The report on the in-vitro and in-vivo micro electrode array market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the extensive use of MEAs in neuroscience research, wide applications of in vitro CMOS-based MEAs, and the advent of 3D nanoparticle printing technology. In addition, Extensive use of MEAs in neuroscience research is anticipated to boost the growth of the market as well.
The in-vitro and in-vivo micro electrode array market analysis includes end-user segment, type segment, and geographical landscapes.
The in-vitro and in-vivo micro electrode array market is segmented as below:
By End-user
- Industrial labs and CROs
- Academic, govt, and other research labs
- Multiwell MEA
- Single well MEA
- North America
- Europe
- Asia
- ROW
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The report on the in-vitro and in-vivo micro electrode array market covers the following areas:
- In-vitro and in-vivo micro electrode array market sizing
- In-vitro and in-vivo micro electrode array market forecast
- In-vitro and in-vivo micro electrode array market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.
This market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- 3Brain AG
- Axion BioSystems Inc.
- Harvard Bioscience Inc.
- MaxWell Biosystems AG
- Neuralynx Inc.
- Neuronexus
- MORE
Executive Summary
Geographic Landscape
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Key Finding 9
9: Parent market
10: Market characteristics
11: Offerings of vendors included in the market definition
12: Market segments
13: Global - Market size and forecast 2019 - 2024 ($ million)
14: Global market: Year-over-year growth 2019 - 2024 (%)
15: Five forces analysis 2019 & 2024
16: Bargaining power of buyers
17: Bargaining power of suppliers
18: Threat of new entrants
19: Threat of substitutes
20: Threat of rivalry
21: Market condition - Five forces 2019
22: End user - Market share 2019-2024 (%)
23: Comparison by End user
24: Industrial labs and CROs - Market size and forecast 2019-2024 ($ million)
25: Industrial labs and CROs - Year-over-year growth 2019-2024 (%)
26: Academic, govt, and other research labs - Market size and forecast 2019-2024 ($ million)
27: Academic, govt, and other research labs - Year-over-year growth 2019-2024 (%)
28: Market opportunity by End user
29: Type - Market share 2019-2024 (%)
30: Comparison by Type
31: Multiwell MEA - Market size and forecast 2019-2024 ($ million)
32: Multiwell MEA - Year-over-year growth 2019-2024 (%)
33: Single well MEA - Market size and forecast 2019-2024 ($ million)
34: Single well MEA - Year-over-year growth 2019-2024 (%)
35: Market opportunity by Type
36: Customer landscape
37: Market share by geography 2019-2024 (%)
38: Geographic comparison
39: North America - Market size and forecast 2019-2024 ($ million)
40: North America - Year-over-year growth 2019-2024 (%)
41: Europe - Market size and forecast 2019-2024 ($ million)
42: Europe - Year-over-year growth 2019-2024 (%)
43: Asia - Market size and forecast 2019-2024 ($ million)
44: Asia - Year-over-year growth 2019-2024 (%)
45: ROW - Market size and forecast 2019-2024 ($ million)
46: ROW - Year-over-year growth 2019-2024 (%)
47: Key leading countries
48: Market opportunity by geography ($ million)
49: Impact of drivers and challenges
50: Vendor landscape
51: Landscape disruption
52: Industry risks
53: Vendors covered
54: Market positioning of vendors
55: 3Brain AG - Overview
56: 3Brain AG - Product and service
57: 3Brain AG - Key offerings
58: 3Brain AG - Key customers
59: 3Brain AG - Segment focus
60: Axion BioSystems Inc. - Overview
61: Axion BioSystems Inc. - Product and service
62: Axion BioSystems Inc. - Key offerings
63: Axion BioSystems Inc. - Key customers
64: Axion BioSystems Inc. - Segment focus
65: Blackrock Microsystems LLC - Overview
66: Blackrock Microsystems LLC - Product and service
67: Blackrock Microsystems LLC - Key offerings
68: Blackrock Microsystems LLC - Key customers
69: Blackrock Microsystems LLC - Segment focus
70: Harvard Bioscience Inc. - Overview
71: Harvard Bioscience Inc. - Business segments
72: Harvard Bioscience Inc. - Key offerings
73: Harvard Bioscience Inc. - Key customers
74: Harvard Bioscience Inc. - Segment focus
75: MaxWell Biosystems AG - Overview
76: MaxWell Biosystems AG - Product and service
77: MaxWell Biosystems AG - Key offerings
78: MaxWell Biosystems AG - Key customers
79: MaxWell Biosystems AG - Segment focus
80: Neuralynx Inc. - Overview
81: Neuralynx Inc. - Product and service
82: Neuralynx Inc. - Key offerings
83: Neuralynx Inc. - Key customers
84: Neuralynx Inc. - Segment focus
85: Neuronexus - Overview
86: Neuronexus - Product and service
87: Neuronexus - Key offerings
88: Neuronexus - Key customers
89: Neuronexus - Segment focus
90: Plexon Inc. - Overview
91: Plexon Inc. - Product and service
92: Plexon Inc. - Key offerings
93: Plexon Inc. - Key customers
94: Plexon Inc. - Segment focus
95: Screen Holdings Co. Ltd. - Overview
96: Screen Holdings Co. Ltd. - Business segments
97: Screen Holdings Co. Ltd. - Key offerings
98: Screen Holdings Co. Ltd. - Key customers
99: Screen Holdings Co. Ltd. - Segment focus
100: Tucker Davis Technologies - Overview
101: Tucker Davis Technologies - Product and service
102: Tucker Davis Technologies - Key offerings
103: Tucker Davis Technologies - Key customers
104: Tucker Davis Technologies - Segment focus
105: Currency conversion rates for US$
106: Research Methodology
107: Validation techniques employed for market sizing
108: Information sources
109: List of abbreviations
- Market Overview
- Market ecosystem
- Market characteristics
- Value chain analysis
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 - 2024
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Market segments
- Comparison by End-user
- Industrial labs and CROs - Market size and forecast 2019-2024
- Market opportunity by End-user
- Market segments
- Comparison by Type
- Multiwell MEA - Market size and forecast 2019-2024
- Single well MEA - Market size and forecast 2019-2024
- Market opportunity by Type
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- Asia - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
- Market drivers
- Market challenges
- Market trends
- Vendor landscape
- Landscape disruption
- Competitive scenario
- Vendors covered
- Market positioning of vendors
- 3Brain AG
- Axion BioSystems Inc.
- Blackrock Microsystems LLC
- Harvard Bioscience Inc.
- MaxWell Biosystems AG
- Neuralynx Inc.
- Neuronexus
- Plexon Inc.
- Screen Holdings Co. Ltd.
- Tucker Davis Technologies
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Key Finding 9
9: Parent market
10: Market characteristics
11: Offerings of vendors included in the market definition
12: Market segments
13: Global - Market size and forecast 2019 - 2024 ($ million)
14: Global market: Year-over-year growth 2019 - 2024 (%)
15: Five forces analysis 2019 & 2024
16: Bargaining power of buyers
17: Bargaining power of suppliers
18: Threat of new entrants
19: Threat of substitutes
20: Threat of rivalry
21: Market condition - Five forces 2019
22: End user - Market share 2019-2024 (%)
23: Comparison by End user
24: Industrial labs and CROs - Market size and forecast 2019-2024 ($ million)
25: Industrial labs and CROs - Year-over-year growth 2019-2024 (%)
26: Academic, govt, and other research labs - Market size and forecast 2019-2024 ($ million)
27: Academic, govt, and other research labs - Year-over-year growth 2019-2024 (%)
28: Market opportunity by End user
29: Type - Market share 2019-2024 (%)
30: Comparison by Type
31: Multiwell MEA - Market size and forecast 2019-2024 ($ million)
32: Multiwell MEA - Year-over-year growth 2019-2024 (%)
33: Single well MEA - Market size and forecast 2019-2024 ($ million)
34: Single well MEA - Year-over-year growth 2019-2024 (%)
35: Market opportunity by Type
36: Customer landscape
37: Market share by geography 2019-2024 (%)
38: Geographic comparison
39: North America - Market size and forecast 2019-2024 ($ million)
40: North America - Year-over-year growth 2019-2024 (%)
41: Europe - Market size and forecast 2019-2024 ($ million)
42: Europe - Year-over-year growth 2019-2024 (%)
43: Asia - Market size and forecast 2019-2024 ($ million)
44: Asia - Year-over-year growth 2019-2024 (%)
45: ROW - Market size and forecast 2019-2024 ($ million)
46: ROW - Year-over-year growth 2019-2024 (%)
47: Key leading countries
48: Market opportunity by geography ($ million)
49: Impact of drivers and challenges
50: Vendor landscape
51: Landscape disruption
52: Industry risks
53: Vendors covered
54: Market positioning of vendors
55: 3Brain AG - Overview
56: 3Brain AG - Product and service
57: 3Brain AG - Key offerings
58: 3Brain AG - Key customers
59: 3Brain AG - Segment focus
60: Axion BioSystems Inc. - Overview
61: Axion BioSystems Inc. - Product and service
62: Axion BioSystems Inc. - Key offerings
63: Axion BioSystems Inc. - Key customers
64: Axion BioSystems Inc. - Segment focus
65: Blackrock Microsystems LLC - Overview
66: Blackrock Microsystems LLC - Product and service
67: Blackrock Microsystems LLC - Key offerings
68: Blackrock Microsystems LLC - Key customers
69: Blackrock Microsystems LLC - Segment focus
70: Harvard Bioscience Inc. - Overview
71: Harvard Bioscience Inc. - Business segments
72: Harvard Bioscience Inc. - Key offerings
73: Harvard Bioscience Inc. - Key customers
74: Harvard Bioscience Inc. - Segment focus
75: MaxWell Biosystems AG - Overview
76: MaxWell Biosystems AG - Product and service
77: MaxWell Biosystems AG - Key offerings
78: MaxWell Biosystems AG - Key customers
79: MaxWell Biosystems AG - Segment focus
80: Neuralynx Inc. - Overview
81: Neuralynx Inc. - Product and service
82: Neuralynx Inc. - Key offerings
83: Neuralynx Inc. - Key customers
84: Neuralynx Inc. - Segment focus
85: Neuronexus - Overview
86: Neuronexus - Product and service
87: Neuronexus - Key offerings
88: Neuronexus - Key customers
89: Neuronexus - Segment focus
90: Plexon Inc. - Overview
91: Plexon Inc. - Product and service
92: Plexon Inc. - Key offerings
93: Plexon Inc. - Key customers
94: Plexon Inc. - Segment focus
95: Screen Holdings Co. Ltd. - Overview
96: Screen Holdings Co. Ltd. - Business segments
97: Screen Holdings Co. Ltd. - Key offerings
98: Screen Holdings Co. Ltd. - Key customers
99: Screen Holdings Co. Ltd. - Segment focus
100: Tucker Davis Technologies - Overview
101: Tucker Davis Technologies - Product and service
102: Tucker Davis Technologies - Key offerings
103: Tucker Davis Technologies - Key customers
104: Tucker Davis Technologies - Segment focus
105: Currency conversion rates for US$
106: Research Methodology
107: Validation techniques employed for market sizing
108: Information sources
109: List of abbreviations
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- 3Brain AG
- Axion BioSystems Inc.
- Harvard Bioscience Inc.
- MaxWell Biosystems AG
- Neuralynx Inc.
- Neuronexus
- MORE
The publisher recognizes the following companies as the key players in the global in-vitro and in-vivo micro electrode array market: 3Brain AG, Axion BioSystems Inc., Blackrock Microsystems LLC, Harvard Bioscience Inc., MaxWell Biosystems AG, Neuralynx Inc., Neuronexus, Plexon Inc., Screen Holdings Co. Ltd., and Tucker Davis Technologies.
Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is potential application in cancer tissue detection."
According to the report, one of the major drivers for this market is the extensive use of meas in neuroscience research.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is potential application in cancer tissue detection."
According to the report, one of the major drivers for this market is the extensive use of meas in neuroscience research.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
- 3Brain AG
- Axion BioSystems Inc.
- Blackrock Microsystems LLC
- Harvard Bioscience Inc.
- MaxWell Biosystems AG
- Neuralynx Inc.
- Neuronexus
- Plexon Inc.
- Screen Holdings Co. Ltd.
- Tucker Davis Technologies
Note: Product cover images may vary from those shown
LOADING...
